Literature DB >> 10522981

Hormonal signaling in prostatic hyperplasia and neoplasia.

M Marcelli1, G R Cunningham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10522981     DOI： 10.1210/jcem.84.10.6083

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  19 in total

1.  Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity.

Authors:  Silvana G P Campos; Bianca F Gonçalves; Wellerson R Scarano; Lara S Corradi; Fernanda C A Santos; Ana M G Custodio; Patricia S L Vilamaior; Rejane M Góes; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

2.  Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia.

Authors:  Pil Moon Kang; Young Jin Kim; Won Tae Seo; Su Hwan Kang; Taek Sang Kim; Bong Kwon Chun; Won Ik Seo; Jee-Yeong Jeong; Jae Il Chung
Journal:  World J Urol       Date:  2018-08-01       Impact factor: 4.226

3.  Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation.

Authors:  Yasuhito Funahashi; Katherine J O'Malley; Naoki Kawamorita; Pradeep Tyagi; Donald B DeFranco; Ryosuke Takahashi; Momokazu Gotoh; Zhou Wang; Naoki Yoshimura
Journal:  Prostate       Date:  2013-12-17       Impact factor: 4.104

4.  Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men.

Authors:  V R Panz; B I Joffe; I Spitz; T Lindenberg; A Farkas; M Haffejee
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

5.  Proliferative, structural and molecular features of the Mdx mouse prostate.

Authors:  Leslie C Pinto; Wagner J Fávaro; Valéria H A Cagnon
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

6.  Androgenic modulation of AR-Vs.

Authors:  Ana Caroline Hillebrand; Lolita Schneider Pizzolato; Gisele Branchini; Ilma Simoni Brum
Journal:  Endocrine       Date:  2018-07-19       Impact factor: 3.633

Review 7.  Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).

Authors:  M Maggi; C Crescioli; A Morelli; E Colli; L Adorini
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

8.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01

9.  The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia.

Authors:  Katherine J O'Malley; Rajiv Dhir; Joel B Nelson; James Bost; Yan Lin; Zhou Wang
Journal:  Prostate       Date:  2009-12-01       Impact factor: 4.104

10.  Disorders related with ageing in the gerbil female prostate (Skene's paraurethral glands).

Authors:  Ana M G Custodio; Fernanda C A Santos; Silvana G P Campos; Patricia Simone Leite Vilamaior; Sérgio M Oliveira; Rejane M Góes; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2009-12-22       Impact factor: 1.925
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.